// App-Quantinova.ai

3976 : Outcomes of Adult Philadelphia Positive Acute Lymphoblastic Leukemia Patients Treated with Pediatric Multi-Agent Chemotherapy and Imatinib and the Impact of Residual Disease Monitoring on Survival

Researchers

Presenter

  • Solaf Sami Kanfar

Principal Investigators

  • Steven M. Chan

  • Vikas Gupta

  • Aaron D. Schimmer

  • Andre C. Schuh

  • Hassan Sibai

  • Karen W.L. Yee

  • Mark D. Minden

Medical Centers

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

  • Department of Surgery, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Imatinib

  • IkT001

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim